Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is poised to improve its operations and outlook with key catalysts, such as the expansion of its biogas and cellulosic ethanol production facilities, potential approval for expanded E15 fuel usage nationwide, and the renewal of federal production tax credits. The company's Q1 revenue growth supports a positive outlook, and although the company's balance sheet remains highly leveraged, its 5-year financial plan to reach $1 billion in revenue in 2025 and $1.5 billion in revenue in 2026 show promising potential for long-term growth and profitability.

Bears say

Aemetis is making strong progress on its biogas and cellulosic ethanol production facility projects, with key catalysts such as monetization of fuel and tax credits, improved ethanol economics, ramping up operations in India, and progress on new sustainable fuel plants. Although the company's financial plan is outdated, its potential for $1 billion in revenue by 2026 and positive regulatory paths, such as approval for expanded E15 fuel usage, make it an attractive investment despite balance sheet and regulatory risks.

Aemetis (AMTX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Jul 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.